Doctors are testing an investigational drug to see if it is safe and works well to increase NASH resolution without worsening of fibrosis. Volunteers who have Precirrhotic non-alcoholic steatohepatitis may be able to join.
ACHIEVE-4 is a clinical research study for people with type 2 diabetes and excess weight who are at risk for heart disease or stroke. The study will test how safe and well the investigational medicine (the medicine being studied) works for blood glucose and weight management compared with insulin therapy.
Can I join this study?
Yes, you may be able to join the research study if you:
- Are aged 18 years or over
- Have type 2 diabetes
- Take at least 1 medicine to manage your diabetes
- Have a BMI* of 25 or higher
- Have or are at risk for heart disease, stroke, or other blood vessel diseases, or have kidney disease
*BMI stands for body mass index. If you do not know your BMI, please contact a healthcare professional.
Worldwide, ATRIAL FIBRILLATION is one of the most common causes of stroke. Researchers are now exploring the use of an investigational drug in patients with atrial fibrillation.
You may qualify if you have a type of heart failure where your heart has less strength than normal to pump blood to your body, and if you have not recently been hospitalized for your heart failure or experienced a worsening of your heart failure that required urgent treatment.
Indago delivers community-based services for Miami and neighboring areas, driving advances in investigational research for new and improved drugs.
Working Hours
Monday-Friday 8:00 AM – 5:00 PM
Saturday (open if necessary)
Sunday (open if necessary)